Related Experiment Video
Updated: Jul 4, 2026

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
Applications of Mitomycin C in Cornea and External Disease
Marcos A Crespo1, Christopher J Rapuano1, Zeba A Syed1
1Wills Eye Hospital, Cornea Service, Philadelphia, USA.
Abstract:
Isolated from Streptomyces caespitosus, mitomycin C (MMC) has various applications in the management of corneal and external disease due to its ability to modulate cellular proliferation. It has been employed in pterygium surgery, ocular surface neoplasia, and refractive surgery. Currently, there is no definite consensus on the treatment protocols for each of the aforementioned applications. Although its benefits in the management of corneal and external diseases are promising, MMC use has potential complications including endothelial cell loss, corneal perforation, scleral melt, secondary glaucoma, iritis, and endophthalmitis. This article will review the literature regarding the use of MMC in the field of cornea and external disease and describe protocols employed with corresponding outcomes.
Related Concept Videos
Studying the Cytoskeleton
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Confocal Fluorescence Microscopy
Angle Closure Glaucoma: Treatment

